Candriam S.C.A. 10x Genomics, Inc. Transaction History

Candriam S.C.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$28.48 - $52.59 $284,800 - $525,900	-10,000 Reduced 41.67%	14,000 $399,000
Q2 2022 Aug 03, 2022	BUY	$36.95 - $82.41 $695,325 - $1.55 Million	18,818 Added 363.14%	24,000 $1.09 Million
Q1 2022 May 13, 2022	BUY	$55.7 - $145.79 $47,233 - $123,629	848 Added 19.57%	5,182 $394,000
Q3 2021 Nov 09, 2021	BUY	$145.58 - $192.14 $95,791 - $126,428	658 Added 17.9%	4,334 $631,000
Q2 2021 Jul 20, 2021	BUY	$134.22 - $202.37 $493,392 - $743,912	3,676 New	3,676 $720,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.